ArticleNPJ precision oncology2022

Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis.

Chao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.